You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

CLINICAL TRIALS PROFILE FOR DURACLON

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Duraclon

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00349921 ↗	Clonidine Versus Adenosine to Treat Neuropathic Pain	Completed	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 2	2004-08-01	The purpose of this study is to determine the effects of clonidine and adenosine on nerve pain.
NCT00349921 ↗	Clonidine Versus Adenosine to Treat Neuropathic Pain	Completed	Wake Forest School of Medicine	Phase 2	2004-08-01	The purpose of this study is to determine the effects of clonidine and adenosine on nerve pain.
NCT00349921 ↗	Clonidine Versus Adenosine to Treat Neuropathic Pain	Completed	Wake Forest University Health Sciences	Phase 2	2004-08-01	The purpose of this study is to determine the effects of clonidine and adenosine on nerve pain.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Duraclon

Condition Name

Chart
Table

Condition Name for Duraclon
Intervention	Trials
Neonatal Abstinence Syndrome	2
Postoperative Pain	2
Labor Pain	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Duraclon
Intervention	Trials
Pain, Postoperative	2
Neonatal Abstinence Syndrome	2
Breakthrough Pain	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Duraclon

Trials by Country

Map
Table

Trials by Country for Duraclon
Location	Trials
United States	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Duraclon
Location	Trials
Maryland	3
Pennsylvania	1
New York	1
Tennessee	1
North Carolina	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Duraclon

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Duraclon
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	1
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Duraclon
Clinical Trial Phase	Trials
Completed	6
Terminated	2
Withdrawn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Duraclon

Sponsor Name

Chart
Table

Sponsor Name for Duraclon
Sponsor	Trials
Johns Hopkins University	3
National Institute on Drug Abuse (NIDA)	2
Gauda, Estelle B., M.D.	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Duraclon
Sponsor	Trials
Other	14
NIH	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.